Concord Drugs Ltd
Concord Drugs | 538965
- Share Price Chart
Stock Performance
Ratios
About Company
- Concord Drugs Limited, established in 1995, is amongst the respected pharmaceutical companies in India for manufacturing of Finished Pharmaceutical Formulations like Injectables (Small Volume parenterals, Dry Syrup powder) ,Tissue Bio-Adhesive, tablets, capsules and ophthalmic preparations and Ready-to-fill Pellets
- The principal activity of the Company is to manufacture licensed drugs based on the formulations approved
- The Company has two manufacturing facilities license issued by The Government of Andhra Pradesh, Drugs Control Administration, and Hyderabad
- State of the art technology having dedicated manufacturing facilities for Liquid Injections, Dry powder Injections and Ready-to-fill Pellets ensures the highest level of process integrity and product quality
- The Company started with Finished Pharmaceutical Formulations and then diversified into Ready-to-fill Pellets, to provide customers with end-to-end solution to their various pharmaceutical product needs to commercial contract drug manufacturing
- It is engaged in developing New products Viz MUPS (Multiple Unit Pellet System), Sustained Release, Modified Release pellets with Innovative Drug Delivery Technologies by utilizing best and latest processing machinery
- It operates a state of the art, cGMP contract manufacturing Formulation-Fill-Finish facility, providing comprehensive pharmaceutical development and manufacturing services for drug products
Research Calls
Technical Indicators
Pivot Points
No Information Available
Volume Analysis data is not available at this time.
Growth Rate
All figures in ₹ Crores
No Information Available
No shareholding data available at this time.
No Data Available
No Block Deals data available for this company.
News
No Information Available
Peers
#IndiaInvests
Trusted by 2.5 lac + Indians for their wealth-building needs
Top Gainers
Group Stocks
Frequently Asked Questions
What is Share Price of Concord Drugs Ltd?
The current share price of Concord Drugs Ltd (Concord Drugs) is ₹76.66. This price reflects the latest market valuation and is updated in real-time during trading hours.
What is the P/E Ratio of Concord Drugs Ltd?
The Price-to-Earnings (P/E) ratio of Concord Drugs Ltd is 76.66. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.
What is the 52-week high and low of Concord Drugs Ltd?
Concord Drugs Ltd has a 52-week high of ₹92.52 and a 52-week low of ₹53.63. This range shows the stock's price volatility over the past year.
What is the Dividend Yield of Concord Drugs Ltd?
Concord Drugs Ltd offers a dividend yield of 0.00%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.
What is the EPS of Concord Drugs Ltd?
The Earnings Per Share (EPS) of Concord Drugs Ltd is ₹1.56. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.
What is the ROE of Concord Drugs Ltd?
Concord Drugs Ltd has a Return on Equity (ROE) of 0.88%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.
Disclaimer:
Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.
